OS Therapies Incorporated OSTX
Set alert
1.26 USD +0.04 +3.28%
As of Nov 2, 9:53 AM ET
1.23 Day range 1.30
1.15 52-week range 2.25
- YTD
- -10.00%
- 1 year
- -32.26%
- Open
- 1.24
- Prev close
- 1.22
- Mkt cap
- 59.44M
- Vol
- 70.95K
- Avg vol
- 588.13K
- EPS
- -1.08
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.23
- High
- 1.30
- Forward P/E
- 2.57
- Beta
- 0.00
- Short ratio
- 1.22
- Inst. own
- 0.75%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 2.72
- 200-d avg
- 3.11
- 1y target
- 12.67
Financial health
Altman Z-Score
-25.65 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
1 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C2 / 5 overall
- DCF 2
- Return on Equity 5
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 1
Valuation
P/E -1.4×
FY 2020 5y median -7.6× FY 2025
P/S 0.0×
FY 2020 5y median 0.0× FY 2025
P/B -6.7×
FY 2020 5y median -3.3× FY 2025
P/FCF -0.0×
FY 2020 5y median -13.1× FY 2025
EV/EBITDA -1.4×
FY 2020 5y median -13.4× FY 2025
EV/Sales 0.0×
FY 2020 5y median 0.0× FY 2025
FCF Yield -34767.1%
FY 2020 5y median -7.6% FY 2025
Profitability
Gross Margin 0.0%
FY 2020 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2020 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2020 5y median 0.0% FY 2025
ROE 471.7%
FY 2020 5y median 35.6% FY 2025
ROIC 582.9%
FY 2020 5y median 78.9% FY 2025
ROA -420.4%
FY 2020 5y median -976.3% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2020 FY 2025
Operating Income -321.3%
FY 2020 FY 2025
EPS (diluted) -88.5%
FY 2020 FY 2025
Free Cash Flow -195423.2%
FY 2020 FY 2025
Financial Health
Current Ratio 0.0×
FY 2020 5y median 0.1× FY 2025
Quick Ratio 0.0×
FY 2020 5y median 0.1× FY 2025
Debt / Equity 0.0×
FY 2020 5y median -0.6× FY 2025
Net Debt / EBITDA 0.0×
FY 2020 5y median -1.4× FY 2025
Interest Coverage 0.0×
FY 2020 5y median -1.9× FY 2025
Dividends
Dividend Yield 0.0%
FY 2020 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2020 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31